Shanghai Henlius Biotech, Inc. (HKG: 2696)
Hong Kong
· Delayed Price · Currency is HKD
20.15
-0.10 (-0.49%)
Nov 15, 2024, 4:08 PM HKT
Shanghai Henlius Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Net Income | 692.34 | 546.02 | -695.26 | -984.05 | -993.54 | -875.47 | Upgrade
|
Depreciation & Amortization | 363.45 | 353.32 | 273.12 | 196.56 | 133.43 | 80.91 | Upgrade
|
Other Amortization | 5.91 | 5.91 | 4.48 | 32.62 | 5.79 | 20.03 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.7 | -0.72 | 0.25 | 0.93 | -0.81 | 0.01 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | -0.01 | 5.3 | Upgrade
|
Stock-Based Compensation | - | 2.59 | 12.52 | 48.42 | 35.73 | 97.12 | Upgrade
|
Provision & Write-off of Bad Debts | 8.3 | 9.03 | 1.64 | 0.17 | - | - | Upgrade
|
Other Operating Activities | 171.7 | 152.88 | 284.19 | 284.61 | 94.17 | 75.97 | Upgrade
|
Change in Accounts Receivable | 67.72 | -283.77 | -161.41 | -99.7 | -340.94 | -28.31 | Upgrade
|
Change in Inventory | -11.02 | -22.34 | -340.64 | -91.71 | -53.73 | -100.23 | Upgrade
|
Change in Accounts Payable | -41.58 | -108.34 | 312.56 | 20.04 | 145.76 | 53.97 | Upgrade
|
Change in Unearned Revenue | 363.47 | 495.12 | 227.14 | 303.83 | 217.6 | 238.97 | Upgrade
|
Change in Other Net Operating Assets | -652.87 | -101.78 | 1,063 | 378.68 | 146.97 | -11.41 | Upgrade
|
Operating Cash Flow | 966.72 | 1,048 | 981.62 | 90.39 | -609.58 | -443.13 | Upgrade
|
Operating Cash Flow Growth | -31.79% | 6.75% | 985.96% | - | - | - | Upgrade
|
Capital Expenditures | -337.47 | -473.67 | -584.97 | -460.43 | -557 | -288.95 | Upgrade
|
Sale of Property, Plant & Equipment | -0.01 | 0.02 | 6.56 | 0.55 | 0.27 | - | Upgrade
|
Cash Acquisitions | -15 | -15 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -563.54 | -537.77 | -780.32 | -670.76 | -955.52 | -632.33 | Upgrade
|
Investment in Securities | -350.16 | -120 | - | - | - | - | Upgrade
|
Other Investing Activities | 141.98 | 141.98 | - | -550.61 | - | -211.65 | Upgrade
|
Investing Cash Flow | -1,124 | -1,004 | -1,359 | -1,681 | -1,512 | -1,133 | Upgrade
|
Long-Term Debt Issued | - | 2,512 | 2,859 | 2,096 | 1,443 | 686.68 | Upgrade
|
Total Debt Issued | 2,843 | 2,512 | 2,859 | 2,096 | 1,443 | 686.68 | Upgrade
|
Long-Term Debt Repaid | - | -2,237 | -1,886 | -1,364 | -392.54 | -635.58 | Upgrade
|
Total Debt Repaid | -2,865 | -2,237 | -1,886 | -1,364 | -392.54 | -635.58 | Upgrade
|
Net Debt Issued (Repaid) | -22.22 | 274.34 | 972.77 | 731.67 | 1,050 | 51.1 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 2,950 | Upgrade
|
Other Financing Activities | -135.66 | -129.91 | -114.75 | -83.36 | -54.66 | -52.96 | Upgrade
|
Financing Cash Flow | -157.88 | 144.43 | 858.02 | 648.3 | 995.79 | 2,948 | Upgrade
|
Foreign Exchange Rate Adjustments | -2.9 | 6.27 | 37.59 | -16.77 | -60.75 | -29.74 | Upgrade
|
Net Cash Flow | -318.25 | 194.19 | 518.49 | -959.33 | -1,187 | 1,342 | Upgrade
|
Free Cash Flow | 629.26 | 574.25 | 396.65 | -370.04 | -1,167 | -732.07 | Upgrade
|
Free Cash Flow Growth | -26.88% | 44.77% | - | - | - | - | Upgrade
|
Free Cash Flow Margin | 11.16% | 10.64% | 12.34% | -21.99% | -198.54% | -805.10% | Upgrade
|
Free Cash Flow Per Share | 1.16 | 1.06 | 0.73 | -0.69 | -2.20 | -1.47 | Upgrade
|
Cash Interest Paid | 135.66 | 129.91 | 114.75 | 83.2 | 28.34 | 35.11 | Upgrade
|
Cash Income Tax Paid | 26.17 | 20.71 | 1.37 | - | - | 0.66 | Upgrade
|
Levered Free Cash Flow | -138.35 | -723.27 | -1,019 | -857.51 | -2,271 | -1,187 | Upgrade
|
Unlevered Free Cash Flow | -63.82 | -654.18 | -952.46 | -804.5 | -2,243 | -1,157 | Upgrade
|
Change in Net Working Capital | 29.77 | 399.37 | -515.54 | -464.88 | 327.7 | -72.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.